HCC Healthcare Inks $5B SPAC Deal with RF Acquisition Corp III for Nasdaq Listing
RFAM is trading near its 52-week low of $9.77 (1.8% above the low).
Summary
RF Acquisition Corp III signed a definitive business combination agreement with HCC Healthcare, valuing the target at $5 billion. The deal paves the way for HCC to list on Nasdaq. This follows a non-binding letter of intent disclosed in April and a 425 filing earlier today. The definitive agreement removes uncertainty and sets a clear valuation, a material step for the SPAC. With RFAM trading near its 52-week high of $9.98, the market appears to be pricing in deal completion. The transaction is subject to shareholder approval and regulatory clearances.
At the time of this announcement, RFAM was trading at $9.95 on NASDAQ in the Finance sector, with a market capitalization of approximately $138.5M. The 52-week trading range was $9.77 to $9.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.